PHYSIOLOGICAL SIGNIFICANCE OF VASCULAR ENDOTHELIAL GROWTH FACTOR IN PATIENTS WITH ACUTE FORMS OF CORONARY ARTERY DISEASE
T.I. Gavrilenko, N.O. Ryzhkova, O.M. Parkhomenko, N.V. Dovgan
NSC « M.D. Strazhesko Institute of Cardiology NAMS of Ukraine, Kyiv, Ukraine
DOI: https://doi.org/10.15407/fz65.05.033
Abstract
A total of 148 patients with acute coronary syndrome,
unstable angina and acute myocardial infarction (AMI),
and 57 practically healthy individualswere examined. The concentration of vascular endothelial growth factor (VEGF)
in the serum of patients with AMI was studied in the dynamics
of treatment. Upon admission to hospital, inall groupsof the
patients therewereno significant differenceswith the control
values. However, in patients with unstable angina the variance
was small. At the same time, a large variation of the values
(0 -1848.2 pg/ml) was found inpatients with AMI. In this
regard, these patients were divided into 3 groups. 1st group
included patients (60.4%) with low levels of VEGF <100 pg/
ml,2nd group (21.9%) - with normal - 100 - 300 pg/ml, 3rd
group (17.7%) - withhigh –> 300 pg/ml. When comparing
1st and 3rdgroupswith 2nd group,it is necessary to note later
admission to hospital, more frequently recorded previously
existing AMI and the presenceof concomitant inflammatory
diseasesin3rdgroup. Dynamic monitoring of the AMI course
during first 7 days of the disease revealed the increase of VEGF
in 1st and 2nd groups and the absence of changes in 3rd group.
Thus, an increase of VEGF in patients with low and “normal”
content of this factor likely indicates its compensatory role
for AMI. The absence of this factorgrowth in patients with its
initially very high value together with a combination of risk
factors may reflects the maximum stress of the compensatory
mechanisms and a suboptimalcourse, from a physiological
point of view,of AMI hospital period.
Keywords:
vascular endothelial growth factor; unstable stenocardia; infarct of myocardium.
References
- Bratus VV, Shumakov VA, Talaeva TV. Atherosclerosis, coronary heart disease, acute coronary syndrome: pathogenesis, diagnosis, clinic, treatment. K.: Chetverta hvyla; 2004. [Russian].
- Gavrilenko TI, Parkhomenko OM, Rizhkova NA, Kozhukhov SM, Yakushko LV. Cytokine profile of mononuclear cells in patients with acute coronary syndrome, accelerated heart failure. Fiziol Zh. 2012;6:23-8. [Ukrainian].
- Moreno PR, Purushothaman R, Fuster V. Plaque neovascularization is increased in ruptured atherosclerotic lesions of human aorta. Implication for plaque vulnerability. Circulation. 2004;110(14): 2032-38.
CrossRef
PubMed
- Ferrara N. Molecular and biological propeties of VEGF. J Mol Med. 1999;77:527-43.
CrossRef
PubMed
- Losordo DW, Diommeler S. Therapeutic angiogenesis and vasculogenesis for ischemic disease. Part 1: angiogenic cytokines. Circulation. 2004;109:2487-91.
CrossRef
PubMed
- Mirzapoiazova T, Kolosova I, Usatyuk PV, Natarajan V, Verin AD. Diverse effects of vascular endothelial growth factor on human pulmonary endothelial barrier and migration. Am J Physiol Lung Cell Mol Physiol. 2006;291:718-24.
CrossRef
PubMed
- Rutanen J, Ylä-Herttuala S. VEGF D expression in human atherosclerotic lesions. Cardiovasc Res. 2003;59:971-9.
CrossRef
- Ferrara N. Vascular endothelial growth factor: Basic science and clinical progress. Endocrin Rev. 2004;25(4):581-611.
CrossRef
PubMed
- Smith GA, Fearnley GW, Tomlinson DC, Ponnambalam S. The cellular response to vascular endothelial growth factors requires coordinated signal transduction, trafficking and proteolysis. Biosci Rep. 2015;35(5): e00253.
CrossRef
PubMed PubMedCentral
- Marino F, Tozzi M, Schembri L, Ferraro S, Tarallo A, Scanzano A, Legnaro M, Castelli P, Cosentino M. Production of IL-8, VEGF and elastase by circulating and intraplaque neutrophils in patients with carotid atherosclerosis. PLoS One. 2015;10(4): e0124565.
CrossRef
PubMed PubMedCentral
- Gavrilenko TI, Ryzhkova NO, Parkhomenko OM. Vascular endothelial growth factor in the clinic of internal diseases and its pathogenetic significance. Ukr Card J. 2011;4:87-95. [Russian].
- Tsukahara T, Tsukahara R, Haniu H, Murakami-Murofushi K. Cyclic phosphatidic acid inhibits the secretion of vascular endothelial growth factor from diabetic human coronary artery endothelial cells through peroxisome proliferator-activated receptor gamma. Mol Cell Endocrinol. 2015;412:320-9.
CrossRef
PubMed
- Kimura K, Hashiguchi T, Deguchi T, Horinouchi S, Uto T, Oku H., Setoyama S, Maruyama I, Osame M, Arimura K. Serum VEGF as a prognostic factor of atherosclerosis. Atherosclerosis. 2007;194:182-8.
CrossRef
PubMed
- Tsutsumi Y, Losordo DW. Double face of VEGF. Circulation. 2005;112:1248-50.
CrossRef
PubMed
- Ryzhkova NO, Gavrilenko TI, Parkhomenko OM, Kozhukhov SM. Metabolic activity of neutrophilic granulocytes and possible ways of its correction in patients with acute coronary syndrome. Fiziol Zh. 2011;57(2):35-42. [Ukrainian].
CrossRef
PubMed
- Hojo Y, Ikeda U, Zhu Y, Okada M, Ueno S, Arakawa H, Fujikawa H, Katsuki T, Shimada K. Expression of vascular endothelial growth factor in patients with acute myocardial infarction. J Am Coll Cardiol. 2000;35:968-73.
CrossRef
- Yang Z, Zou J. Expression of vascular endothelial growth factor in cardiac repair: Signaling mechanisms mediating vascular protective effects. Int J Biol Macromol. 2018;113:179-85.
CrossRef
PubMed
- Shurygin M, Shurygina I, Kanya O, Lushnikova EL, Nepomnyashchikh RD. Morphological evaluation of oxidative phosphorylation system in myocardial infarction under conditions of modified vascular endothelial growth factor concentration. Bull Exp Biol Med. 2015;159(3):402-5.
CrossRef
PubMed
- Chung HJ, Kim JT, Kim HJ,Katila P,Lee JH,Yang TH,Yang YI, Lee SJ. Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction. J Control Release. 2015;205:218-30.
CrossRef
PubMed
- Zheng W, Seftor EA, Meininger CJ, Hendrix MJ, Tomanek RJ Mechanisms of coronary angiogenesis in response to stretch: role of VEGF and TGFQ. Am J Phisiol Heart Circ Phisiol. 2001;280:909-17.
CrossRef
PubMed
- Wang JN, Zhang L, Zheng F, Yang JY, Kong X, Guo LY, Chen L, Huang YZ, Wan Y, Chen SY. VEGF. SDF1 promotes cardiac stem cell mobilization and myocardial repair in the infarcted heart. Cardiovasc Reaseach. 2011;91:402-11.
CrossRef
PubMed PubMedCentral
- Zhu Z, Chen AF. Inhibition of PKR impairs angiogenesis through a VEGF pathway. Am J Physiol Endocrinol. 2015;308(6):518-24.
CrossRef
PubMed
|